在高血压中循环microRNA thiazide反应的生物标志物
Lakshmi Manasa S Chekka1, Marwa Tantawy1, Taimour Langaee1
1Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine University of Florida Gainesville FL.
Journal of the American Heart Association
|February 14, 2024
概括
循环中的microRNAs (miRNAs) 显示出潜在的生物标志物,用于预测患者对高血压治疗中的 thiazide 利尿剂的反应. 识别这些miRNA可以指导个性化选择抗高血压药物.
科学领域:
- 基因组学和精准医学精准医学
- 心血管研究研究心血管研究
- 生物标志物发现发现
背景情况:
- thiazide 利尿剂是常见的高血压治疗方法,但疗效在患者之间有很大的差异.
- 高达50%的个体对 thiazides 的反应很小,需要使用替代治疗策略.
- 识别预测生物标志物对于优化 thiazide 利尿剂选择至关重要.
研究的目的:
- 探索循环中的microRNAs (miRNAs) 作为潜在的生物标志物,用于预测高血压中 thiazide 尿液反应.
- 为了确定与对甲和甲的差异反应相关的特定miRNAs.
主要方法:
- 血miRNA分析对高血压患者进行了分析,这些患者被分类为对甲的反应者或不反应者.
- 分析了差异性miRNA表达,并在多个队列中验证了候选miRNA.
- 多变量回归分析评估了miRNA表达和血压反应之间的关联,并根据临床因素进行调整.
主要成果:
- 选择了19个miRNA进行验证,其中miR-193b-3p和miR-30d-5p显示出与欧洲裔美国人的血压反应有显著的关联.
- 在综合分析中,let-7g,miR-142-3p和miR-423-5p与分类血压反应有关.
- 这些miRNA的预测点基因参与关键的高血压相关途径,包括 lysine 降解和脂肪酸代谢.
结论:
- 循环中的miRNAs,包括let-7g,miR-142-3p,miR-193b-3p,miR-423-5p和miR-30d-5p,显示为提亚尿剂反应的预测生物标志物.
- 这些miRNAs可能有助于临床选择适合的 thiazide 利尿剂用于个人高血压管理.
- 需要进一步的研究来将这些发现转化为个性化高血压治疗的常规临床实践.
相关概念视频
01:22Heart Failure Drugs: Diuretics
381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
555
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
555
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
731
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
731
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431